The VHIO-CRIS Precision Intelligence & Oncology Network for Enhanced Evidence & Research (PIONEER) Program drives innovation in precision oncology and digital transformation by strengthening multimodal data integration and sharing across VHIO’s research groups. By harmonizing and connecting diverse datasets, the program enhances their application in clinical decision support and reinforces the institute’s Transversal Services Unit, further consolidating VHIO’s data-driven research ecosystem.

The program aims to position VHIO and CRIS as leaders in cutting-edge data analytics and large-scale research studies that drive the development of new therapies. It also fosters the creation of digital tools for diagnosis, prognosis, prediction, and prevention, with the ultimate goal of improving patient outcomes and maintaining VHIO’s leadership in cancer research.

Driving Innovation in Data Science and Oncology

The VHIO-CRIS PIONEER program supports the establishment of new multimodal data digitalization units, including Oncology Data Science (Odyssey) Group, Bioinformatics Unit, Biostatistics Unit, and Data Engineering for Research Unit. These units work collaboratively to expand VHIO’s capabilities in data-driven oncology research.

A central focus of the program is the development of digital platforms for the integration and analysis of multimodal oncology data, encompassing transcriptomics, genomics, immunomics, metagenomics, and epigenomics. 

In parallel, the program promotes the creation of AI-powered tools for advanced data and medical image analysis, including radiomics and digital pathology, thereby accelerating the implementation of precision medicine. 

The initiative also aims to reinforce end-user trust—particularly among medical oncologists and biomedical researchers—by enhancing the transparency and explainability of the models employed. Furthermore, it seeks to increase societal awareness of the responsible use of patient data in research by empowering patients, their representatives, and related associations. 

Technological Framework

Through its advanced technological framework, the program supports key research initiatives, including:

• Investigating the impact of the exposome on cancer patients with solid tumors.
• Conducting large-scale analyses of immune evasion mechanisms in various cancer types.
• Performing multidimensional (Real-World Data) and molecular analyses to identify causal and predictive factors for cancer.

Knowledge Sharing, Training, and Talent Development

Beyond research, the VHIO-CRIS program actively promotes knowledge exchange, education, and talent attraction. The Bioinformatics Unit coordinates an internal network dedicated to sharing expertise and optimizing resources.

One of its flagship initiatives is the Biocomputational-Bioinformatics Journal Club, a monthly forum where participants discuss emerging topics in the field. In addition, to further support young talent, the program sponsors the Computational Oncology Master’s Thesis Award, recognizing outstanding research in Computational Life Sciences from Spanish universities.

Patient Engagement

PIONNER has been designed to increase societal awareness about the use of patient data in research. We aim to empower patients, their representatives, and related associations through the strategic leverage of VHIO’s PATIENTS program.

This Program aims, on one hand to empower and educate patients and citizens in research and in general cancer knowledge, to empower them in decision making; and on the other hand, by empowering patients we will bring added value to VHIO’s projects, introducing the patient’s perspective in the design of oncology research projects.

PIONNER leverages of the advancements made by the Severo Ochoa Unit of Digital Oncology (SOUND, CEX2020-001024-S / AEI / 10.13039 / 501100011033), the Digital Oncology Group (DOG, 2021SGR1571) and the Research Data Management working group.